Structural circles are actually shadows
This could open entirely new treatment categories and support the next phase of market expansion. Implications for Other Industries Food companies may be among the most exposed to increased GLP-1 adoption, as patients typically reduce calorie intake while on these therapies
Eli Lilly and Ascidian reach a global agreement to develop RNA exon editing drugs On June 3, 2026, Ascidian Therapeutics announced today that it has reached a global research collaboration and licensing agreement with Ei Lily and Company
Often referred to as the sleep hormone, melatonin is also widely studied for its broader involvement in cellular processes, mitochondrial activity, and oxidative balance
Patients with type 2 diabetes or obesity who meet criteria for GLP-1 therapy may experience additional lipid benefits, particularly those with mixed dyslipidaemia, metabolic syndrome, or established cardiovascular disease